Calcipotriene And Betamethasone Dipropionate Suspension
Product Images NDC 51672-1402

7 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Calcipotriene And Betamethasone Dipropionate (NDC 51672-1402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Calcipotriene 01)

Chemical Structure (Calcipotriene 01)
Chemical structure of Calcipotriene, an active ingredient in Calcipotriene and Betamethasone Dipropionate topical suspension, shown as a detailed 2D molecular diagram with rings, bonds, and hydroxyl groups.*
FDA Label Image

Chemical Structure (Calcipotriene 02)

Chemical Structure (Calcipotriene 02)
Chemical structure of Calcipotriene and Betamethasone Dipropionate, the active ingredients in the provided topical suspension product by Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Figure A (Calcipotriene 03)

Figure A (Calcipotriene 03)
An instructional illustration showing a hand holding a bottle labeled "Calcipotriene & Beta Dip Topical" with a double-headed arrow above indicating shaking or mixing of the suspension before use.*
FDA Label Image

Figure B (Calcipotriene 04)

Figure B (Calcipotriene 04)
An instructional illustration showing a person using both hands to part their hair at the scalp. The image focuses on the forehead and hairline area, demonstrating how to prepare the scalp for topical application.*
FDA Label Image

Figure C (Calcipotriene 05)

Figure C (Calcipotriene 05)
An instructional illustration showing the use of Calcipotriene and Betamethasone Dipropionate topical suspension. The image depicts a person dispensing the suspension from a bottle onto their finger for topical application.*
FDA Label Image

Figure D (Calcipotriene 06)

Figure D (Calcipotriene 06)
An instructional diagram showing a person using both hands to carefully twist or remove a cap or seal from a container near the forehead. The drawing is black and white, focusing on hand positioning and action around the upper face and container opening.*
FDA Label Image

Principal Display Panel (60 g Bottle Carton)

Principal Display Panel (60 g Bottle Carton)
Packaging label for Calcipotriene and Betamethasone Dipropionate topical suspension, 0.005%/0.064%, net weight 60 g. The label indicates it is for topical use only and includes manufacturer information for Sun Pharmaceutical Industries, Inc. The label includes usage instructions such as shaking before use, storage conditions, and warnings to keep out of reach of children. The label also features a barcode and trademark information for Taro Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.